Invasive Fungal Disease in Patients with Myeloid Malignancies: A Retrospective Cohort Study of a Diagnostic-Driven Care Pathway Withholding Mould-Active Prophylaxis.
Elizabeth A de KortJochem B BuilSteven SchalekampCornelia Schaefer-ProkopPaul E VerweijNicolaas P M SchaapNicole M A BlijlevensWalter J F M Van der VeldenPublished in: Journal of fungi (Basel, Switzerland) (2022)
Diagnostic-driven based management without universal mould active prophylaxis is a feasible strategy in the management of IFD and limits unnecessary antimould treatment during intensive chemotherapy. The poor performance of serial serum galactomannan screening in detecting IA warrants further investigation.